Stone Warren, President and Chief Operating Officer of NeoGenomics Inc. ($NEO), made one open market purchase of NEO shares in the last year, totaling nearly $49,000, with the most recent on May 12, 2025. This ranks 3,074th among 4,983 insiders by purchase value, well below the $1.5 million average across 3.3 transactions. He also sold NEO shares once for about $277,000, most recently on January 20, 2026, ranking 7,734th out of 11,678 insiders versus the $8.6 million average over 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 6911 | $0.00 | 158,365.0000 | 129,812,211 | 4.18% | 0.01% |
| April 1, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 17562 | $0.00 | 165,276.0000 | 129,812,211 | 11.89% | 0.01% |
| April 1, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Restricted Stock Unit | 17562 | $0.00 | 339,277.0000 | 129,812,211 | 4.92% | 0.01% |
| March 1, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | A | Stock Option (Right to Buy) | 253378 | $0.00 | 563,482.0000 | 129,812,211 | 81.71% | 0.20% |
| March 1, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | A | Restricted Stock Unit | 152594 | $0.00 | 356,839.0000 | 129,812,211 | 74.71% | 0.12% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 28105 | $0.00 | 149,736.0000 | 129,812,211 | 23.11% | 0.02% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Restricted Stock Unit | 28105 | $0.00 | 195,802.0000 | 129,812,211 | 12.55% | 0.02% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 3323 | $0.00 | 147,714.0000 | 129,812,211 | 2.20% | 0.00% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 8443 | $0.00 | 151,037.0000 | 129,812,211 | 5.92% | 0.01% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 7142 | $0.00 | 142,594.0000 | 129,812,211 | 4.77% | 0.01% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Restricted Stock Unit | 8443 | $0.00 | 148,033.0000 | 129,812,211 | 5.40% | 0.01% |
| Jan. 20, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | S | Common Stock | 22128 | $12.50 | 121,631.0000 | 129,387,801 | 15.39% | 0.02% |
| Jan. 13, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 59382 | $0.00 | 158,886.0000 | 129,387,801 | 59.68% | 0.05% |
| Jan. 13, 2026 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 15127 | $0.00 | 143,759.0000 | 129,387,801 | 9.52% | 0.01% |
| Dec. 1, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 8776 | $0.00 | 99,504.0000 | 129,387,801 | 8.10% | 0.01% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 9613 | $0.00 | 104,921.0000 | 128,461,383 | 10.09% | 0.01% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 2341 | $0.00 | 102,580.0000 | 128,461,383 | 2.23% | 0.00% |
| May 12, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | P | Common Stock | 5700 | $8.58 | 108,280.0000 | 128,461,383 | 5.56% | 0.00% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Restricted Stock Unit | 9613 | $0.00 | 240,793.0000 | 128,461,383 | 3.84% | 0.01% |
| May 2, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | M | Common Stock | 5969 | $0.00 | 96,762.0000 | 128,461,383 | 6.57% | 0.00% |
| May 2, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | F | Common Stock | 1454 | $0.00 | 95,308.0000 | 128,461,383 | 1.50% | 0.00% |
| April 1, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | A | Stock Option (Right to Buy) | 94518 | $0.00 | 310,104.0000 | 128,461,383 | 43.84% | 0.07% |
| April 1, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Pres & Chief Operating Officer | A | Restricted Stock Unit | 52687 | $0.00 | 250,406.0000 | 128,461,383 | 26.65% | 0.04% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Restricted Stock Unit | 84317 | $0.00 | 180,833.0000 | 128,461,383 | 87.36% | 0.07% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | M | Restricted Stock Unit | 8443 | $0.00 | 113,402.0000 | 128,461,383 | 6.93% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | M | Common Stock | 8443 | $0.00 | 93,265.0000 | 128,461,383 | 9.95% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | F | Common Stock | 2472 | $0.00 | 90,793.0000 | 128,461,383 | 2.65% | 0.00% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Stock Option (Right to Buy) | 143266 | $0.00 | 215,586.0000 | 128,461,383 | 198.10% | 0.11% |
| Jan. 14, 2025 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Restricted Stock Unit | 59382 | $0.00 | 121,845.0000 | 0 | 95.07% | 0.00% |
| Dec. 1, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | F | Common Stock | 6224 | $0.00 | 84,822.0000 | 0 | 6.84% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | M | Restricted Stock Unit | 9612 | $0.00 | 62,463.0000 | 0 | 13.34% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | M | Common Stock | 9612 | $0.00 | 93,387.0000 | 0 | 11.47% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | F | Common Stock | 2341 | $14.86 | 91,046.0000 | 0 | 2.51% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | M | Common Stock | 9612 | $0.00 | 100,658.0000 | 0 | 10.56% | 0.00% |
| May 2, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Stock Option (Right to Buy) | 29976 | $0.00 | 72,320.0000 | 0 | 70.79% | 0.00% |
| May 2, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Performance Stock Unit | 17908 | $0.00 | 64,442.0000 | 0 | 38.48% | 0.00% |
| May 2, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | Chief Commerical Officer | A | Restricted Stock Unit | 17908 | $0.00 | 72,075.0000 | 0 | 33.06% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | President, Clinical Services | A | Stock Option (Right to Buy) | 42344 | $0.00 | 42,344.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | President, Clinical Services | A | Performance Stock Unit | 25330 | $0.00 | 46,534.0000 | 0 | 119.46% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Stone Warren | President, Clinical Services | A | Restricted Stock Unit | 25329 | $0.00 | 54,167.0000 | 0 | 87.83% | 0.00% |